Design, Synthesis and Biological Assessment of Aryl-Isoxazole-Integrated Pyrimidin-2-yl Oxazolo[4,5-b]pyridine Derivatives as Anticancer Agents
A novel series of aryl-isoxazole-containing pyrimidin-2-yl oxazolo [4,5b]pyridine derivatives (11a-j) was designed and synthesized, and their structures were established using appropriate analytical and spectroscopic techniques.The newly synthesized compounds were subsequently subjected to preliminary in vitro anticancer evaluation against four human cancer cell lines, namely breast cancer (MCF-7), lung cancer (A549), colon cancer (Colo-205), and ovarian cancer (A2780), using the MTT assay.The synthesized compounds exhibited moderate to good cytotoxic effects when compared with etoposide, which was employed as the reference drug.Among the synthesized derivatives, compounds 11a, 11b, 11h, 11i, and 11j showed higher activity than the reference compound.Notably, derivative 11h demonstrated the most pronounced anticancer activity within the synthesized series.
Authors
- N. Saritha
- Khasim Saheb Shaik
Publication Details
- Journal
- International Journal of Scientific Research in Science and Technology
- Published
- 2026-11-20
- DOI
- https://doi.org/10.32628/ijsrst13132614
- Primary Topic
- Heterocyclic Compound Synthesis and Bioactivity
- Type
- article
- Field-Weighted Citation Impact
- 0.00